Identification of potential prostate cancer preventive agents through induction of quinone reductase in vitro

Cancer Epidemiology Biomarkers and Prevention

Volumn 11, Issue 9, 2002, Pages 868-875

  Brooks, James D ^a   Goldberg, Michael F ^a   Nelson, Linda A ^a   Wu, David ^a   Nelson, William G ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIOXIDANT; ARSENIC DERIVATIVE; AZACITIDINE; BENZYL ISOTHIOCYANATE; BUTYLATED HYDROXYANISOLE; BUTYLCRESOL; CADMIUM CHLORIDE; CATECHOL; COUMARIN; ENZYME INDUCING AGENT; ETHYLENE GLYCOL; GLUTATHIONE TRANSFERASE; HEAVY METAL; HYDROQUINONE; ISOTHIOCYANIC ACID DERIVATIVE; MENADIONE; MERCURIC CHLORIDE; PEROXIDE; PHENETHYL ISOTHIOCYANATE; PHENOL DERIVATIVE; PHENYL ISOTHIOCYANATE; QUINONE DERIVATIVE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE; RESORCINOL; TETRAZOLIUM; THIOL DERIVATIVE; UNINDEXED DRUG; ZINC CHLORIDE;

ARTICLE; CANCER CELL CULTURE; DRUG EFFICACY; DRUG POTENCY; ENZYME INDUCTION; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION;

ANTICARCINOGENIC AGENTS; CELL LINE; DRUG SCREENING ASSAYS, ANTITUMOR; ENZYME INDUCTION; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HEPATOBLASTOMA; HUMANS; ISOENZYMES; LIVER NEOPLASMS; MALE; PROSTATE; PROSTATIC NEOPLASMS; QUINONE REDUCTASES; TUMOR CELLS, CULTURED;

EID: 0036716819     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (68)

1. Cancer statistics, 2001
2. Epidemiologic evidence regarding predisposing factors to prostate cancer
3. Comparative epidemiology of cancers of the colon, rectum, prostate and breast in Shanghai, China versus the United States
4. Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County
5. Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada
6. Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese men in the United States
7. Prostate cancer: Trends in mortality and stage-specific incidence rates by racial/ ethnic group in Los Angeles County, California (United States)
8. Major susceptibility locus for prostate cancer on chromosome I suggested by a genome-wide search
9. Evidence for a prostate cancer susceptibility locus on the X chromosome
10. Evidence for a prostate cancer-susceptibility locus on chromosome 20
11. The CAG repeat within the androgen receptor gene and its relationship to prostate cancer
12. A candidate prostate cancer susceptibility gene at chromosome 17p
13. Chemoprevention of prostate cancer: The Prostate Cancer Prevention Trial
14. Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis
15. CG island methylation changes near the GSTP1 gene in prostatic carcinoma cells detected using the polymerase chain reaction: A new prostatic biomarker
16. GSTP1 CpG island hypermethylation is responsible for the absence of GSTP1 expression in human prostate cancer cells
17. CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia
18. Increased skin tumorigenesis in mice lacking pi class glutathione S-transferases
19. Inhibition of carcinogenesis by minor dietary constituents
20. Chemoprotection against cancer by phase 2 enzyme induction
21. Rapid detection of inducers of enzymes that protect against carcinogens
22. A major inducer of anticarcinogenic protective enzymes from broccoli: Isolation and elucidation of structure
23. Chemical and molecular regulation of enzymes that detoxify carcinogens
24. Induction of NAD(P)H: Quinone reductase in murine hepatoma cells by phenolic antioxidants, azo dyes, and other chemoprotectors: A model system for the study of anticarcinogens
25. Broccoli sprouts: An exceptionally rich source of inducers of enzymes that protect against chemical carcinogens
26. Mutagenicity of quinones: Pathways of metabolic activation and detoxification
27. Catechol estrogen metabolites and conjugates in different regions of the prostate of Noble rats treated with 4-hydroxyestradiol: Implications for estrogen-induced initiation of prostate cancer
28. Induction of glutathione transferases and NAD(P)H: Quinone reductase by fumaric acid derivatives in rodent cells and tissues
29. Anticarcinogenic activities of sulforaphane and structurally related synthetic norbornyl isothiocyanates
30. Direct measurement of NAD(P)H: Quinone reductase from cells cultured in microtiter wells: A screening assay for anticarcinogenic enzyme inducers
31. Elevation of serum phase 11 enzymes by anticarcinogenic enzyme inducers: Markers for a chemoprotected state?
32. Tissue-specific induction patterns of cancer-protective enzymes in mice by tert-butyl-4-hydroxyanisole and related substituted phenols
33. Effect of oltipraz, α-tocopherol, β-carotene and phenethylisothiocyanate on rat oesophageal, gastric, colonic and hepatic glutathione, glutathione S-transferase and peroxidase
34. Quantitation of tissue- and sex-specific induction of rat GSH transferase subunits by dietary 1,2-dithiole-3-thiones
35. The glutathione S-transferase supergene family: Regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance
36. Potent induction of phase 2 enzymes in human prostate cells by sulforaphane
37. Protection against 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine cytotoxicity and DNA adduct formation in human prostate by glutathione S-transferase PI
38. Protective alterations in phase 1 and 2 metabolism of aflatoxin B1 by oltipraz in residents of Qidong, People's Republic of China
39. Chemoprotection by organosulfur inducers of phase 2 enzymes: Dithiolethiones and dithiins
40. Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nfr2 transcription factor-deficient mice
41. Molecular basis for the contribution of the antioxidant responsive element to cancer chemoprevention
42. The potency of inducers of NAD(P)H:(quinone-acceptor) oxidoreductase parallels their efficiency as substrates for glutathione transferases. Structural and electronic correlations
43. Identification of a common chemical signal regulating the induction of enzymes that protect against chemical carcinogenesis
44. The electrophile counterattack response: Protection against neoplasia and toxicity
45. Potency of Michael reaction acceptors as inducers of enzymes that protect against carcinogenesis depends on their reactivity with sulfhydryl groups
46. Role of glutathione in the accumulation of anticarcinogenic isothiocyanates and their glutathione conjugates by murine hepatoma cells
47. Molecular mechanism of rapid cellular accumulation of anticarcinogenic isothiocyanates
48. Total intracellular accumulation levels of dietary isothiocyanates determine their activity in elevation of cellular glutathione and induction of phase 2 detoxification enzymes
49. Systematic variation in gene expression patterns in human cancer cell lines
50. New molecular approaches for identifying novel targets, mechanisms, and biomarkers for prostate cancer chemopreventive agents
51. Relation of structure of curcumin, analogs to their potencies as inducers of phase 2 detoxification enzymes
52. Curcumin, an antioxidant and anti-tumor promoter, induces apoptosis in human leukemia cells
53. Curcuminoids as potent inhibitors of lipid peroxidation
54. Proliferative inflammatory atrophy of the prostate: Implications for prostatic carcinogenesis
55. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: Down-regulation of COX-2 and iNOS through suppression of NF-κB activation
56. Lack of chemopreventive effects of lycopene and curcumin on experimental rat prostate carcinogenesis
57. Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo
58. Chemoprotective properties of phenylpropenoids, bis(benzylidene)cycloalkanones, and related Michael reaction acceptors: Correlation of potencies as phase 2 enzyme inducers and radical scavengers
59. Prenylated chalcones and flavanones as inducers of quinone reductase in mouse Hepa1c1c7 cells
60. Fruit and vegetable intakes and prostate cancer risk
61. Vegetables, fruits, legumes and prostate cancer: A multiethnic case-control study
62. Vegetable and fruit consumption in relation to prostate cancer risk in Hawaii: A reevaluation of the effect of dietary β-carotene
63. Dietary intake of isothiocyanates: Evidence of a joint effect with glutathione S-transferase polymorphisms in lung cancer risk
64. Serum selenium and subsequent risk of prostate cancer
65. Plasma selenium level before diagnosis and the risk of prostate cancer development
66. Intake of carotenoids and retinol in relation to risk of prostate cancer
67. Tomatoes, tomato-based products, lycopene, and cancer: Review of the epidemiologic literature
68. Lycopene as the most efficient biological carotenoid singlet oxygen quencher